Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EORTC Brain Tumor Group: achievements and perspectives.

Ch J Vecht1, M J van den Bent, D Lacombe

  • 1Neuro-oncology Unit, Department of Neurology, Medical Center Haaglanden/Westeinde, POB 432, 2501 CK, The Hague, The Netherlands. c.vecht@mchaaglanden.nl

European Journal of Cancer (Oxford, England : 1990)
|February 23, 2002
PubMed
Summary

The EORTC Brain Tumor Group is restructuring to lead large international clinical trials and early drug development for gliomas. This strategic adaptation has increased participation and established the group as a major clinical research player.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Neurology·2025
Same author

Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress.

Redox biology·2025
Same author

Longitudinal analysis of cognitive function in patients treated with postoperative radiotherapy for grade 2 and 3 IDH mutant diffuse glioma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0.

European journal of nuclear medicine and molecular imaging·2025
Same author

Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.

BMC health services research·2023
Same author

Thirty years of progress in the management of low-grade gliomas.

Revue neurologique·2023

Area of Science:

  • Neuro-oncology
  • Clinical trial management
  • Drug development

Background:

  • The European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group has a history of accomplishments.
  • Recent restructuring addresses the need for large intergroup/intercontinental trials and early drug development for gliomas.

Purpose of the Study:

  • To outline the strategic restructuring of the EORTC Brain Tumor Group.
  • To highlight the group's adaptation to quality assurance and translational research.
  • To detail the group's achievements and future strategies in neuro-oncology clinical research.

Main Methods:

  • The article details the strategic re-structuring of the EORTC Brain Tumor Group.
  • Focus on adaptation to higher quality assurance criteria.

Related Experiment Videos

  • Implementation of translational research studies.

    • Main Results:

    • The EORTC Brain Tumor Group has become a major player in clinical research.
    • Significant increase in participating centers and patients over the past two years.
    • Successful adaptation to new challenges in clinical trial management.

    Conclusions:

    • The EORTC Brain Tumor Group's strategic restructuring has enhanced its capabilities.
    • The group is well-positioned for future large-scale international trials and early drug development in gliomas.
    • Continued focus on quality assurance and translational research is key to its success.